Skip to main content
. 2020 Sep 27;21(19):7140. doi: 10.3390/ijms21197140

Figure 2.

Figure 2

Frequency of dysregulated miRNAs in MDS and sAML. Close to 89% of the investigated miRNAs (n = 46) showed a deregulation of miRNA in MDS or sAML when compared to healthy controls, in which 33% are sAML-related and 56% are MDS-related. Approximately 11% of deregulated miRNAs overlapped in both diseases (11%).